Breaking News

Dalton Wins U.S. Army Contract

To support anti-malarial drug development program

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dalton Pharma Services has entered into a contract service agreement with the United States Army Medical Materiel Development Activity (USAMMDA) to support its product development program for the treatment of severe or complicated malaria due to Plasmodium falciparum. Dalton will provide cGMP sterile powder filling, aseptic liquid filling, quality control release testing and ICH stability services.   Malaria remains a major infectious disease threat to service members deployed to endemic areas...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters